Hinge Health Inc. Class A Common Stock vs iShares Semiconductor ETF — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while iShares Semiconductor ETF trades at $512.4 (market cap $44.53B). The key difference: iShares Semiconductor ETF is far larger — about 5.3× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, iShares Semiconductor ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and iShares Semiconductor ETF for 47 Days on average.
| HNGE | SOXX | |
|---|---|---|
Market Cap | $8.48B | $44.53B |
Volume | 879,799 | 8,354,155 |
Sector | Health | Sector/Thematic |
52-Week High | $105.14 | $655.01 |
52-Week Low | $31.17 | $268.10 |
Typical Hold Time | 0 Days | 47 Days |
Enterprise Value | $8.10B | — |
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
SOXX trades at $543.9, down 0.17% on the day, with technical indicators showing a bearish bias despite oversold RSI conditions. The semiconductor ETF faces mixed sentiment with strong AI-driven earnings growth projections but elevated valuation concerns. Recent news highlights Michael Burry's expanded short position while other analysts point to continued earnings momentum supporting the sector.
The semiconductor sector outlook remains bifurcated between strong AI-driven fundamentals and valuation risks. SOXX's investment case hinges on sustained AI infrastructure demand, though current technical weakness and high multiples relative to broader markets warrant caution. Key risks include sector concentration and potential AI development slowdowns.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →